| For: | Kang YB, Cai Y. Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”. World J Gastroenterol 2022; 28(20): 2248-2250 [PMID: 35721889 DOI: 10.3748/wjg.v28.i20.2248] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i20/2248.htm |
| Number | Citing Articles |
| 1 |
Qiyi Wang, Dingyang Lu, Liuya Xu, Xingyan Liu, Peili Wang, Liu Liu, Xiaofei Li, Jianyong Zhang. Comprehensive fecal metabolomics and 16S rRNA gene sequencing for the exploration of the mechanism of sodium cantharidinate in the treatment of hepatocellular carcinoma. Journal of Pharmaceutical and Biomedical Analysis 2027; 284 doi: 10.1016/j.jpba.2026.117792
|
| 2 |
Chenfang Zhang, Dan Zhang, Xin Wen, Shui Liu. Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1808109
|
| 3 |
Miao Guo, Congyue Zhang. Current status and challenges of immune checkpoint inhibitors in liver cancer: from monotherapy to combination strategies. Medical Oncology 2026; 43(9) doi: 10.1007/s12032-026-03355-x
|